Skip to main content
Back to News
BioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, fol...
Product
1 min read
US

BioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, fol...

The AMW Read

This is an incremental update for a player in the Vertical AI Healthcare segment, marking a transition from concept to regulated medical device through FDA clearance.
NoveltySignificance
Healthcare & Bio Β· Player Map

BioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, following a 3-year validation process. The tool, trained on hundreds of thousands of diverse ultrasounds, ensures anatomical completeness to reduce misdiagnosis in the US. This milestone transitions the platform from an award-winning concept to a regulated medical device addressing maternal health disparities. Scaling across national health systems is now the priority to improve outcomes. πŸ₯πŸ‘Ά

#AI #MedTech #FDA #HealthTech

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 3d agoInnovaccer acquires CaduceusHealth to expand AI-led revenue cycle managementInnovaccer
  2. 1w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  3. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  4. 1mo agoOpenAI Launches GPT-Rosalind, a Specialized Frontier Model for Life Sciences Research and Drug DiscoveryOpenAI
  5. 4mo agoBioticsAI has received FDA clearance for its AI software designed to detect fetal abnormalities, fol... Β· THIS ARTICLE

More news from BioticsAI

Stay updated with the latest news and announcements from BioticsAI.

View all BioticsAI news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard